Semaglutide Versus Dulaglutide and Liraglutide in Chinese Patients With <scp>T2DM</scp> : A Multicenter Real‐World Study
Semaglutide demonstrated superior glycemic control and weight loss compared to both dulaglutide and liraglutide, whereas dulaglutide and liraglutide exhibited comparable clinical efficacy.
Authors
- Zeyu Xie (ORCID: https://orcid.org/0000-0002-1609-4377)
- Jisheng Chen (ORCID: https://orcid.org/0000-0003-3514-9086)
- Bin Gan (ORCID: https://orcid.org/0000-0001-5489-663X)
- Jiang Liu (ORCID: https://orcid.org/0000-0001-6281-6505)
- Weiling Cao (ORCID: https://orcid.org/0000-0002-9077-7918)
Institutions
- Shenzhen University (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Shenzhen Bao'an District People's Hospital (CN)
- Shenzhen Luohu People's Hospital (CN)
Publication Details
- Journal
- Obesity
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1002/oby.70065
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59